GENE ONLINE|News &
Opinion
Blog

Cstone Pharmaceuticals
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
2022-03-30
CStone Wins Hong Kong Approval for Gastrointestinal Tumor Drug
2021-12-29
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
Pfizer Strengthens Immuno-Oncology Portfolio with $200 Million Investment in Chinese Startup
2020-10-03
Weekly Cover:Updates on COVID-19 in Asia
2020-04-08
Weekly in Asia|Nov-2
2019-11-27
Weekly in Asia 2019|AUG-3
2019-08-25
Weekly in Asia 2019|AUG
2019-08-10
Weekly in Asia 2019|JULY-1
2019-07-19
Weekly in Asia 20190609-0615
2019-06-21
Weekly in Asia 20190602-0608
2019-06-11
Weekly in Asia (0519-0525)
2019-05-29
Weekly in Asia(0414-0420)
2019-04-26
Weekly Top 5 in China (0317-0323)
2019-03-25
Weekly Top 5 in China (0217-0223)
2019-02-22
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top